Our projectsBrilliant scientists, powerful collaborations. We find and fund projects that are ripe for treating Duchenne now.
Newly funded projects
Modifying the protein LTBP4 to target inflammation and fibrosis – two key challenges in Duchenne.
Non-invasive imaging biomarker
Reducing biopsies and improving dystrophin analysis in Duchenne boys.
Measuring disease progression and response to new treatments.
Some of our past projects
Dystrophic dogs provide insights into Duchenne research.
Pre-clinical research for drug to target muscle fibrosis.
Increasing utrophin to compensate for dystrophin.
We aim to stop Duchenne muscular dystrophy being a death sentence for hundreds of thousands of boys worldwide.
We are helping turn the hope of treatments into reality. Critical supportive drugs are in clinical trial thanks to our funds.
In the last 3 years we have given more than £1.5m to ground-breaking research projects.
And there is still work to do.